406 related articles for article (PubMed ID: 15456244)
1. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.
Tarzia G; Duranti A; Tontini A; Piersanti G; Mor M; Rivara S; Plazzi PV; Park C; Kathuria S; Piomelli D
J Med Chem; 2003 Jun; 46(12):2352-60. PubMed ID: 12773040
[TBL] [Abstract][Full Text] [Related]
4. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
[TBL] [Abstract][Full Text] [Related]
5. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Mor M; Lodola A; Rivara S; Vacondio F; Duranti A; Tontini A; Sanchini S; Piersanti G; Clapper JR; King AR; Tarzia G; Piomelli D
J Med Chem; 2008 Jun; 51(12):3487-98. PubMed ID: 18507372
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
8. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
9. Tandem mass spectrometric data-FAAH inhibitory activity relationships of some carbamic acid O-aryl esters.
Basso E; Duranti A; Mor M; Piomelli D; Tontini A; Tarzia G; Traldi P
J Mass Spectrom; 2004 Dec; 39(12):1450-5. PubMed ID: 15578755
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
12. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
[TBL] [Abstract][Full Text] [Related]
13. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship studies of O-biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors.
Moreno-Sanz G; Duranti A; Melzig L; Fiorelli C; Ruda GF; Colombano G; Mestichelli P; Sanchini S; Tontini A; Mor M; Bandiera T; Scarpelli R; Tarzia G; Piomelli D
J Med Chem; 2013 Jul; 56(14):5917-30. PubMed ID: 23822179
[TBL] [Abstract][Full Text] [Related]
18. Oxime carbamate--discovery of a series of novel FAAH inhibitors.
Sit SY; Conway CM; Xie K; Bertekap R; Bourin C; Burris KD
Bioorg Med Chem Lett; 2010 Feb; 20(3):1272-7. PubMed ID: 20036536
[TBL] [Abstract][Full Text] [Related]
19. Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system.
Gattinoni S; De Simone C; Dallavalle S; Fezza F; Nannei R; Amadio D; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
ChemMedChem; 2010 Mar; 5(3):357-60. PubMed ID: 20112328
[No Abstract] [Full Text] [Related]
20. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.
Lodola A; Mor M; Sirirak J; Mulholland AJ
Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]